Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis

Correlation between 18F FDG uptake with histopathological prognostic factors in breast carcinoma

Ozgul Ekmekcioglu, Anar Aliyev, Zubeyde Rana Kaya Doner, Fatma Caliskan, Esra Arslan, Melih Engin Erkan, Sait Sager, Metin Halac and Kerim Sonmezoglu
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 72;
Ozgul Ekmekcioglu
1Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anar Aliyev
1Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zubeyde Rana Kaya Doner
1Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fatma Caliskan
1Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esra Arslan
1Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melih Engin Erkan
2Nuclear Medicine, Duzce University, Duzce, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sait Sager
1Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Metin Halac
1Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerim Sonmezoglu
1Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

72

Objectives Although FDG PET/CT is widely used as breast tumor imaging,usage of FDG uptake as prognostic factor is controversial.FDG uptake of tumor is biological indicator and related with prognostic factors.Aim for this study is searching relationship between primary tumor FDG uptake and histopathological prognostic factors.

Methods 136 women and 4 men which has proven breast carcinoma received FDG PET/CT imaging for initial staging.Maximum standardized uptake values and tumor to background SUVmax ratios were calculated and compared with prognostic factors.The calculation of SUVmax for men and statistics considered in their own group and properties.

Results For women, high tumor SUVmax was significantly correlated with histologic type, tumor size, histologic grade, pleomorphism, mitotic count, lymphatic invasion, necrosis, ER negativity, Ki67 level, axillary involvement and triple negativity. PR status, cerbB2 overexpression, perineural invasion, calcification, degree of desmoplasia, tubular formation, age did not correlate with FDG uptake. Also there was significant relationship between tumor to background SUVmax ratios and tumor size, histologic grade, pleomorphism, lymphatic invasion, necrosis,Ki67 level, axillary involvement. There was no significant relationship between tumor to contralateral breast SUVmax ratio and histologic type, mitotic count, ER status, triple negativity. Between other tumor to background ratios have significant relationship with these prognostic parameters. For men, mean SUVmax was calculated and properties were studied particularly.

Conclusions Primary tumor FDG uptake showed correlation with tumor histologic type, tumor size, histologic grade, pleomorphism, mitotic count, lymphatic invasion, necrosis, ER negativity, Ki67 level, axillary involvement and triple negativity. Also it has been proven that Ki67 level and tumor size were decisive factors for the high FDG uptake values. In conclusion FDG uptake may determine tumor biological behaviour as a prognostic factor in breast cancer.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Correlation between 18F FDG uptake with histopathological prognostic factors in breast carcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Correlation between 18F FDG uptake with histopathological prognostic factors in breast carcinoma
Ozgul Ekmekcioglu, Anar Aliyev, Zubeyde Rana Kaya Doner, Fatma Caliskan, Esra Arslan, Melih Engin Erkan, Sait Sager, Metin Halac, Kerim Sonmezoglu
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 72;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Correlation between 18F FDG uptake with histopathological prognostic factors in breast carcinoma
Ozgul Ekmekcioglu, Anar Aliyev, Zubeyde Rana Kaya Doner, Fatma Caliskan, Esra Arslan, Melih Engin Erkan, Sait Sager, Metin Halac, Kerim Sonmezoglu
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 72;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis

  • The Significance of Adrenal Hypermetabolism on FDG PET/CT Scans of Various Cancer Patients: Any Clues for Differential Diagnosis?
  • Bone scan response to newer therapies in castration resistant prostate cancer.
  • Preliminary analysis of dynamic [68Ga]PSMAHBED-CC PET/MRI in primary prostate cancer
Show more Oncology: Clinical Diagnosis

Molecular Imaging of Breast Cancer II

  • Assessing PERCIST 1.0 non-measurable (low FDG uptake) lesions in patients with breast cancer does not diminish the predictive value of FDG PET
  • Integrin receptor imaging of breast cancer using 99mTc-3PRGD2 SPECT/CT: Compared with 18F-FDG PET/CT
  • Prediction of the disease free survival in patients with advanced breast cancer after first cycle of neoadjuvant chemotherapy using parallel PET/MR
Show more Molecular Imaging of Breast Cancer II

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire